Zimmer Biomet Holdings Pre-Tax Profit Margin 2010-2023 | ZBH
Current and historical pre-tax profit margin for Zimmer Biomet Holdings (ZBH) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Zimmer Biomet Holdings pre-tax profit margin for the three months ending December 31, 2023 was .
| Zimmer Biomet Holdings Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $7.40B | $1.07B | 14.44% |
| 2023-09-30 | $7.28B | $0.71B | 9.73% |
| 2023-06-30 | $7.20B | $0.67B | 9.27% |
| 2023-03-31 | $7.11B | $0.59B | 8.30% |
| 2022-12-31 | $6.94B | $0.40B | 5.82% |
| 2022-09-30 | $6.89B | $0.40B | 5.73% |
| 2022-06-30 | $6.91B | $0.41B | 5.91% |
| 2022-03-31 | $6.89B | $0.39B | 5.60% |
| 2021-12-31 | $6.83B | $0.50B | 7.31% |
| 2021-09-30 | $6.24B | $0.95B | 15.20% |
| 2021-06-30 | $6.48B | $1.01B | 15.63% |
| 2021-03-31 | $5.94B | $0.61B | 10.31% |
| 2020-12-31 | $6.13B | $-0.11B | -1.71% |
| 2020-09-30 | $7.07B | $-0.18B | -2.56% |
| 2020-06-30 | $7.03B | $-0.25B | -3.59% |
| 2020-03-31 | $7.79B | $0.11B | 1.41% |
| 2019-12-31 | $7.98B | $0.91B | 11.35% |
| 2019-09-30 | $7.93B | $-0.25B | -3.14% |
| 2019-06-30 | $7.87B | $-0.28B | -3.56% |
| 2019-03-31 | $7.89B | $-0.20B | -2.56% |
| 2018-12-31 | $7.93B | $-0.27B | -3.42% |
| 2018-09-30 | $7.93B | $0.47B | 5.94% |
| 2018-06-30 | $7.91B | $0.44B | 5.62% |
| 2018-03-31 | $7.85B | $0.42B | 5.38% |
| 2017-12-31 | $7.80B | $0.46B | 5.95% |
| 2017-09-30 | $7.73B | $0.62B | 8.00% |
| 2017-06-30 | $7.75B | $0.60B | 7.69% |
| 2017-03-31 | $7.74B | $0.51B | 6.60% |
| 2016-12-31 | $7.67B | $0.40B | 5.23% |
| 2016-09-30 | $7.61B | $0.50B | 6.61% |
| 2016-06-30 | $7.53B | $0.43B | 5.72% |
| 2016-03-31 | $6.77B | $0.08B | 1.20% |
| 2015-12-31 | $6.00B | $0.15B | 2.55% |
| 2015-09-30 | $5.29B | $0.21B | 3.92% |
| 2015-06-30 | $4.63B | $0.41B | 8.75% |
| 2015-03-31 | $4.65B | $0.88B | 18.94% |
| 2014-12-31 | $4.67B | $0.94B | 20.09% |
| 2014-09-30 | $4.69B | $1.08B | 23.06% |
| 2014-06-30 | $4.66B | $1.05B | 22.53% |
| 2014-03-31 | $4.65B | $1.01B | 21.73% |
| 2013-12-31 | $4.62B | $1.01B | 21.80% |
| 2013-09-30 | $4.56B | $0.86B | 18.93% |
| 2013-06-30 | $4.52B | $0.90B | 19.95% |
| 2013-03-31 | $4.47B | $0.99B | 22.21% |
| 2012-12-31 | $4.47B | $0.99B | 22.13% |
| 2012-09-30 | $4.46B | $0.99B | 22.27% |
| 2012-06-30 | $4.47B | $1.01B | 22.69% |
| 2012-03-31 | $4.48B | $0.97B | 21.76% |
| 2011-12-31 | $4.45B | $0.98B | 21.99% |
| 2011-09-30 | $4.42B | $0.90B | 20.36% |
| 2011-06-30 | $4.35B | $0.90B | 20.72% |
| 2011-03-31 | $4.27B | $0.87B | 20.29% |
| 2010-12-31 | $4.22B | $0.86B | 20.40% |
| 2010-09-30 | $4.19B | $0.98B | 23.40% |
| 2010-06-30 | $4.20B | $0.92B | 21.98% |
| 2010-03-31 | $4.17B | $1.00B | 24.08% |
| 2009-12-31 | $4.10B | $1.00B | 24.39% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.889B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |